English

MONOPAR THERAPEUTICS INC.

EDGAR

MNPR Quarterly report (10-Q) · filed 2026-08-12

Annual consolidated revenue for 2025: about USD 0, using the latest reported figures. The previous period, 2024, was about USD 0.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2026-06-30 · USD

Exact inputs and evidence

Revenue: 0 USD Source
Revenue: 0 USD Source

Operating cash flow

-3.25 million USD

2026-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -6721343 USD Source
Operating Cash Flow: -3473906 USD Source

Cash and cash equivalents: 52.8 million USD 2026-06-30 Source
Exact value

52757766 USD
Long-term debt including current maturities: Not available
Shares outstanding: 6.71 million shares 2026-06-30 Source
Exact value

6712172 shares

Reported share-count change

9.54% · 585 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

6127457 shares · 2025-06-30· Source
6712172 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-17.8 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -3438000 USD · 2025-07-01 – 2025-09-30 Source
Net income: -13717000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -8516000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -3893050 USD · 2026-01-01 – 2026-03-31 Source
Net income: -5313000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-12.2 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -8831219 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -6740687 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -12201291 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -8831219 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -3473906 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -6721343 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -3473906 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-12.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2025-12-31
Operating income: 10 of 11 periods available· newest 2025-12-31
Net income: 10 of 11 periods available· newest 2025-12-31
Operating cash flow: 10 of 11 periods available· newest 2025-12-31
capital expenditure: No compatible figures in this window
Total assets: 6 of 11 periods available· newest 2025-12-31
Total liabilities: 6 of 11 periods available· newest 2025-12-31
Current assets: 6 of 11 periods available· newest 2025-12-31
Current liabilities: 6 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 6 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
USD 0

Prior period

USD 0

2024-01-01 – 2024-12-31
Current period

USD 0

2025-01-01 – 2025-12-31

Exact inputs and evidence

0 − 0 = 0 USD

0 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
0 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · MONOPAR THERAPEUTICS INC. · 2025-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Year-over-year change in Revenue: 0 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 0 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000143774926010025/mnpr20251231_10k.htm#15199 Filing: 000143774926010025 Input fundies:Revenue: 0 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000143774925009979/mnpr20241231_10k.htm#7945 Filing: 000143774925009979
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 1.87 million

Prior period

−USD 15.59 million

2024-01-01 – 2024-12-31
Current period

−USD 13.72 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-13717000 − -15586000 = 1869000 USD

-15586000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-13717000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · MONOPAR THERAPEUTICS INC. · 2025-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Year-over-year change in Net income: 1869000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -13717000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000143774926010025/mnpr20251231_10k.htm#1703769 Filing: 000143774926010025 Input fundies:NetIncome: -15586000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000143774926010025/mnpr20251231_10k.htm#1704453 Filing: 000143774926010025
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 5.8 million

Prior period

−USD 6.4 million

2024-01-01 – 2024-12-31
Current period

−USD 12.2 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-12201291 − -6404139 = -5797152 USD

-6404139 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-12201291 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · MONOPAR THERAPEUTICS INC. · 2025-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Year-over-year change in Operating cash flow: -5797152 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -12201291 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000143774926010025/mnpr20251231_10k.htm#1237619 Filing: 000143774926010025 Input fundies:OperatingCashFlow: -6404139 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000143774926010025/mnpr20251231_10k.htm#1238388 Filing: 000143774926010025
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 0
Operating costs Derived USD 16.7 million
Operating income −USD 16.7 million
Tax, interest and other Derived −USD 2.99 million
Net income −USD 13.72 million

Cash

Operating cash flow −USD 12.2 million
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Not shown: operating income or net income is not reported.
2017 Not shown: operating income or net income is not reported.
2018 Not shown: operating income or net income is not reported.
2019 Not shown: operating income or net income is not reported.
2024 Not shown: operating income or net income is not reported.
2025 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	1192829 Derived	-1192829	-7232 Derived	-1185597	Unavailable	Source 2016-01-01 – 2016-12-31: 0 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -1192829 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -1185597 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -1194632 USD Inspect Operating Cash Flow Open source
2017 2017-01-01 – 2017-12-31	16603127 Derived	-16603127	-48255 Derived	-16554872	Unavailable	Source 2017-01-01 – 2017-12-31: 0 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -16603127 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -16554872 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -2627468 USD Inspect Operating Cash Flow Open source
2018 2018-01-01 – 2018-12-31	3331147 Derived	-3331147	-103215 Derived	-3227932	Unavailable	Source 2018-01-01 – 2018-12-31: 0 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -3331147 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -3227932 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -2680487 USD Inspect Operating Cash Flow Open source
2019 2019-01-01 – 2019-12-31	4323761 Derived	-4323761	-98887 Derived	-4224874	Unavailable	Source 2019-01-01 – 2019-12-31: 0 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -4323761 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -4224874 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -3017680 USD Inspect Operating Cash Flow Open source
2024 2024-01-01 – 2024-12-31	16161721 Derived	-16161721	-575721 Derived	-15586000	Unavailable	Source 2024-01-01 – 2024-12-31: 0 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -16161721 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -15586000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -6404139 USD Inspect Operating Cash Flow Open source
2025 2025-01-01 – 2025-12-31	16704415 Derived	-16704415	-2987415 Derived	-13717000	Unavailable	Source 2025-01-01 – 2025-12-31: 0 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: -16704415 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -13717000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -12201291 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2025

Values and sources

Revenue values and source evidence
Period	Series	Source evidence
20162016-12-31	Revenue	Revenue: 0 Open source
20172017-12-31	Revenue	Revenue: 0 Open source
20182018-12-31	Revenue	Revenue: 0 Open source
20192019-12-31	Revenue	Revenue: 0 Open source
20242024-12-31	Revenue	Revenue: 0 Open source
20252025-12-31	Revenue	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20172017-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20182018-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20192019-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source
20242024-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20252025-12-31	Year over year	No prior comparable period	Revenue: 0 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	Not reported	Operating Income: -1192829 Open source Revenue: 0 Open source
20172017-12-31	Operating margin	Not reported	Operating Income: -16603127 Open source Revenue: 0 Open source
20182018-12-31	Operating margin	Not reported	Operating Income: -3331147 Open source Revenue: 0 Open source
20192019-12-31	Operating margin	Not reported	Operating Income: -4323761 Open source Revenue: 0 Open source
20242024-12-31	Operating margin	Not reported	Operating Income: -16161721 Open source Revenue: 0 Open source
20252025-12-31	Operating margin	Not reported	Operating Income: -16704415 Open source Revenue: 0 Open source
20162016-12-31	Net margin	Not reported	Net Income: -1185597 Open source Revenue: 0 Open source
20172017-12-31	Net margin	Not reported	Net Income: -16554872 Open source Revenue: 0 Open source
20182018-12-31	Net margin	Not reported	Net Income: -3227932 Open source Revenue: 0 Open source
20192019-12-31	Net margin	Not reported	Net Income: -4224874 Open source Revenue: 0 Open source
20242024-12-31	Net margin	Not reported	Net Income: -15586000 Open source Revenue: 0 Open source
20252025-12-31	Net margin	Not reported	Net Income: -13717000 Open source Revenue: 0 Open source
20162016-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -1194632 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -2627468 Open source
20182018-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -2680487 Open source
20192019-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -3017680 Open source
20242024-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -6404139 Open source
20252025-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -12201291 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -12.2M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	-1194632	Operating Cash Flow: -1194632 Open source
20172017-12-31	Operating cash flow	-2627468	Operating Cash Flow: -2627468 Open source
20182018-12-31	Operating cash flow	-2680487	Operating Cash Flow: -2680487 Open source
20192019-12-31	Operating cash flow	-3017680	Operating Cash Flow: -3017680 Open source
20242024-12-31	Operating cash flow	-6404139	Operating Cash Flow: -6404139 Open source
20252025-12-31	Operating cash flow	-12201291	Operating Cash Flow: -12201291 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1194632 Open source
20172017-12-31	Free cash flow	Unavailable	Operating Cash Flow: -2627468 Open source
20182018-12-31	Free cash flow	Unavailable	Operating Cash Flow: -2680487 Open source
20192019-12-31	Free cash flow	Unavailable	Operating Cash Flow: -3017680 Open source
20242024-12-31	Free cash flow	Unavailable	Operating Cash Flow: -6404139 Open source
20252025-12-31	Free cash flow	Unavailable	Operating Cash Flow: -12201291 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

2.1% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Liabilities / assets	2.2%	Total Liabilities: 64510 Open source Total Assets: 2895566 Open source
20172017-12-31	Liabilities / assets	3.1%	Total Liabilities: 311867 Open source Total Assets: 9931267 Open source
20182018-12-31	Liabilities / assets	5.5%	Total Liabilities: 399551 Open source Total Assets: 7317955 Open source
20192019-12-31	Liabilities / assets	5.4%	Total Liabilities: 724165 Open source Total Assets: 13352021 Open source
20242024-12-31	Liabilities / assets	8.7%	Total Liabilities: 5254300 Open source Total Assets: 60291071 Open source
20252025-12-31	Liabilities / assets	2.1%	Total Liabilities: 2890156 Open source Total Assets: 140717709 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

51.35× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	32.48×	Current Assets: 2095173 Open source Current Liabilities: 64510 Open source
20172017-12-31	Current assets / current liabilities	29.28×	Current Assets: 9131236 Open source Current Liabilities: 311867 Open source
20182018-12-31	Current assets / current liabilities	18.15×	Current Assets: 7252224 Open source Current Liabilities: 399551 Open source
20192019-12-31	Current assets / current liabilities	18.27×	Current Assets: 13229640 Open source Current Liabilities: 724165 Open source
20242024-12-31	Current assets / current liabilities	11.47×	Current Assets: 60291071 Open source Current Liabilities: 5254300 Open source
20252025-12-31	Current assets / current liabilities	51.35×	Current Assets: 140462788 Open source Current Liabilities: 2735236 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 1.19 million Exact value Exact value: -1185597 USD 2016-01-01 – 2016-12-31: -1185597 USD Inspect Net Income Open source Share or cite Citation for Net Income · MONOPAR THERAPEUTICS INC. · 2016-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Net Income: -1185597 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1185597 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000165495418003136/mono-20171231.xml#35587 Filing: 000165495418003136 The citation records this snapshot. The page link may show a newer release later.	−USD 1.19 million Exact value Exact value: -1194632 USD 2016-01-01 – 2016-12-31: -1194632 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MONOPAR THERAPEUTICS INC. · 2016-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Operating Cash Flow: -1194632 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1194632 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000165495418003136/mono-20171231.xml#43810 Filing: 000165495418003136 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2017-01-01 – 2017-12-31	−USD 16.55 million Exact value Exact value: -16554872 USD 2017-01-01 – 2017-12-31: -16554872 USD Inspect Net Income Open source Share or cite Citation for Net Income · MONOPAR THERAPEUTICS INC. · 2017-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Net Income: -16554872 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16554872 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000165495419009689/mono-20190630.xml#92064 Filing: 000165495419009689 The citation records this snapshot. The page link may show a newer release later.	−USD 2.63 million Exact value Exact value: -2627468 USD 2017-01-01 – 2017-12-31: -2627468 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MONOPAR THERAPEUTICS INC. · 2017-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Operating Cash Flow: -2627468 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2627468 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000165495419009689/mono-20190630.xml#108578 Filing: 000165495419009689 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2018 2018-01-01 – 2018-12-31	−USD 3.23 million Exact value Exact value: -3227932 USD 2018-01-01 – 2018-12-31: -3227932 USD Inspect Net Income Open source Share or cite Citation for Net Income · MONOPAR THERAPEUTICS INC. · 2018-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Net Income: -3227932 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3227932 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000165495420003363/mono-20191231.xml#33975 Filing: 000165495420003363 The citation records this snapshot. The page link may show a newer release later.	−USD 2.68 million Exact value Exact value: -2680487 USD 2018-01-01 – 2018-12-31: -2680487 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MONOPAR THERAPEUTICS INC. · 2018-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Operating Cash Flow: -2680487 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2680487 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000165495420003363/mono-20191231.xml#39262 Filing: 000165495420003363 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2019 2019-01-01 – 2019-12-31	−USD 4.22 million Exact value Exact value: -4224874 USD 2019-01-01 – 2019-12-31: -4224874 USD Inspect Net Income Open source Share or cite Citation for Net Income · MONOPAR THERAPEUTICS INC. · 2019-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Net Income: -4224874 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4224874 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000165495421003243/mono-20201231.xml#36944 Filing: 000165495421003243 The citation records this snapshot. The page link may show a newer release later.	−USD 3.02 million Exact value Exact value: -3017680 USD 2019-01-01 – 2019-12-31: -3017680 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MONOPAR THERAPEUTICS INC. · 2019-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Operating Cash Flow: -3017680 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3017680 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000165495421003243/mono-20201231.xml#44878 Filing: 000165495421003243 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2020-01-01 – 2020-12-31	−USD 6.3 million Exact value Exact value: -6304573 USD 2020-01-01 – 2020-12-31: -6304573 USD Inspect Net Income Open source Share or cite Citation for Net Income · MONOPAR THERAPEUTICS INC. · 2020-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Net Income: -6304573 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6304573 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000165495422003701/mnpr_10k.htm#919475 Filing: 000165495422003701 The citation records this snapshot. The page link may show a newer release later.	−USD 4.66 million Exact value Exact value: -4662274 USD 2020-01-01 – 2020-12-31: -4662274 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MONOPAR THERAPEUTICS INC. · 2020-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Operating Cash Flow: -4662274 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4662274 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000165495422003701/mnpr_10k.htm#929419 Filing: 000165495422003701 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	−USD 9.1 million Exact value Exact value: -9103224 USD 2021-01-01 – 2021-12-31: -9103224 USD Inspect Net Income Open source Share or cite Citation for Net Income · MONOPAR THERAPEUTICS INC. · 2021-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Net Income: -9103224 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9103224 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000165495423003384/mnpr_10k.htm#886044 Filing: 000165495423003384 The citation records this snapshot. The page link may show a newer release later.	−USD 7.32 million Exact value Exact value: -7317401 USD 2021-01-01 – 2021-12-31: -7317401 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MONOPAR THERAPEUTICS INC. · 2021-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Operating Cash Flow: -7317401 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7317401 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000165495423003384/mnpr_10k.htm#944025 Filing: 000165495423003384 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2022 2022-01-01 – 2022-12-31	−USD 10.52 million Exact value Exact value: -10516000 USD 2022-01-01 – 2022-12-31: -10516000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MONOPAR THERAPEUTICS INC. · 2022-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Net Income: -10516000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10516000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000143774924009687/mnpr20231231_10k.htm#1635681 Filing: 000143774924009687 The citation records this snapshot. The page link may show a newer release later.	−USD 7.23 million Exact value Exact value: -7228559 USD 2022-01-01 – 2022-12-31: -7228559 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MONOPAR THERAPEUTICS INC. · 2022-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Operating Cash Flow: -7228559 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7228559 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000143774924009687/mnpr20231231_10k.htm#1309415 Filing: 000143774924009687 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2023 2023-01-01 – 2023-12-31	−USD 8.4 million Exact value Exact value: -8402000 USD 2023-01-01 – 2023-12-31: -8402000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MONOPAR THERAPEUTICS INC. · 2023-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Net Income: -8402000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8402000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000143774925009979/mnpr20241231_10k.htm#1516970 Filing: 000143774925009979 The citation records this snapshot. The page link may show a newer release later.	−USD 7.86 million Exact value Exact value: -7858293 USD 2023-01-01 – 2023-12-31: -7858293 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MONOPAR THERAPEUTICS INC. · 2023-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Operating Cash Flow: -7858293 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7858293 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000143774925009979/mnpr20241231_10k.htm#1135790 Filing: 000143774925009979 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2024 2024-01-01 – 2024-12-31	−USD 15.59 million Exact value Exact value: -15586000 USD 2024-01-01 – 2024-12-31: -15586000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MONOPAR THERAPEUTICS INC. · 2024-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Net Income: -15586000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -15586000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000143774926010025/mnpr20251231_10k.htm#1704453 Filing: 000143774926010025 The citation records this snapshot. The page link may show a newer release later.	−USD 6.4 million Exact value Exact value: -6404139 USD 2024-01-01 – 2024-12-31: -6404139 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MONOPAR THERAPEUTICS INC. · 2024-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Operating Cash Flow: -6404139 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6404139 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000143774926010025/mnpr20251231_10k.htm#1238388 Filing: 000143774926010025 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2025 2025-01-01 – 2025-12-31	−USD 13.72 million Exact value Exact value: -13717000 USD 2025-01-01 – 2025-12-31: -13717000 USD Inspect Net Income Open source Share or cite Citation for Net Income · MONOPAR THERAPEUTICS INC. · 2025-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Net Income: -13717000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13717000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000143774926010025/mnpr20251231_10k.htm#1703769 Filing: 000143774926010025 The citation records this snapshot. The page link may show a newer release later.	−USD 12.2 million Exact value Exact value: -12201291 USD 2025-01-01 – 2025-12-31: -12201291 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · MONOPAR THERAPEUTICS INC. · 2025-12-31 MONOPAR THERAPEUTICS INC. (edgar:1645469) Operating Cash Flow: -12201291 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T13:21:25Z Snapshot: 3f5df86619482508054e1ac222e2deb5220cd3b84d0127379179dd4188fcc437 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1645469/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12201291 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1645469/000143774926010025/mnpr20251231_10k.htm#1237619 Filing: 000143774926010025 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

63 filings · 1,595 latest values · 1,595 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001645469, 1645469, MNPR, edgar:1645469

Also known as MONOPAR THERAPEUTICS INC., Monopar Therapeutics, Monopar Therapeutics Inc.

MONOPAR THERAPEUTICS INC.

Latest quarter

Revenue

Operating cash flow

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation